Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Revolution Medicines, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues20.226.6
            Revenue growth-24.2% 
Cost of goods sold60.531.1
Gross profit-40.3-4.5
            Gross margin-200.0%-17.1%
General and administrative9.44.5
EBITA-40.1-31.1
            EBITA margin-199.0%-117.1%
Amortization of intangibles0.2 
EBIT-40.3-31.1
            EBIT margin-200.0%-117.1%
Pre-tax income-41.8-31.1
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin-0.2%-0.1%
 
Diluted EPS($21.24)($20.25)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy